BEACOPP protocol

chemotherapy protocol consisting of above seven compounds for treating Hodgkin's disease

Networked: 4 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Therapy Context: Research Results

Therapeutics: 1158551
- Drug Therapy: 293145
  - Combination Drug Therapy: 12066
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - BEACOPP protocol: 4
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - BEACOPP protocol: 4
- Clinical Protocols
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - BEACOPP protocol: 4
Carbohydrates: 22023
- Glycosides: 2119
  - Aminoglycosides: 5131
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        Doxorubicin: 35390
        BEACOPP protocol: 4
  - Glucosides: 639
    - Etoposide: 10706
      - BEACOPP protocol: 4
- Glycoconjugates: 1353
  - Glycopeptides: 1928
    - Bleomycin: 9833
      - BEACOPP protocol: 4
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Glycopeptides: 1928
    - Bleomycin: 9833
      - BEACOPP protocol: 4
Organic Chemicals: 133
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthalenes: 18
    - Tetrahydronaphthalenes: 1
      - Podophyllotoxin: 562
        Etoposide: 10706
        BEACOPP protocol: 4
  - Naphthacenes
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        Doxorubicin: 35390
        BEACOPP protocol: 4
- Fused-Ring Compounds
  - Steroids: 70059
    - Pregnanes: 9
      - Pregnadienes
        Pregnadienediols
        Prednisone: 12650
        BEACOPP protocol: 4
Heterocyclic Compounds: 198
- Alkaloids: 5398
  - Indole Alkaloids: 200
    - Secologanin Tryptamine Alkaloids: 81
      - Vinca Alkaloids: 463
        Vincristine: 9251
        BEACOPP protocol: 4
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - Indole Alkaloids: 200
        Secologanin Tryptamine Alkaloids: 81
        Vinca Alkaloids: 463
        Vincristine: 9251
        BEACOPP protocol: 4
    - Indolizines: 3
      - Indolizidines: 2
        Indole Alkaloids: 200
        Secologanin Tryptamine Alkaloids: 81
        Vinca Alkaloids: 463
        Vincristine: 9251
        BEACOPP protocol: 4

Experts

1.	Albano, Domenico: 1 article (05/2017)
2.	Brancatelli, Giuseppe: 1 article (05/2017)
3.	Galia, Massimo: 1 article (05/2017)
4.	Grassedonio, Emanuele: 1 article (05/2017)
5.	La Grutta, Ludovico: 1 article (05/2017)
6.	Lagalla, Roberto: 1 article (05/2017)
7.	Midiri, Massimo: 1 article (05/2017)
8.	Mulè, Antonino: 1 article (05/2017)
9.	Patti, Caterina: 1 article (05/2017)
10.	Elbl, L: 1 article (04/2006)

Related Diseases

1.	Hodgkin Disease (Hodgkin's Disease) 01/01/2001 - "In a patient with Hodgkin's disease who failed to achieve complete remission with the escalated BEACOPP protocol, progression with bone marrow infiltration and B symptoms developed despite further treatment. " 04/01/2006 - "The study was conducted to compare the presence of cardiotoxicity after the treatment of Hodgkin's disease with the standard ABVD or BEACOPP protocol. " 01/01/1996 - "The Stanford group initiated the 12-week intensified hybrid protocol Stanford V. The German Hodgkin's Lymphoma Study Group (GHSG) introduced the BEACOPP protocol with time intensification and dose escalation of cyclophosphamide and etoposide. "
2.	Cardiotoxicity 04/01/2006 - "The study was conducted to compare the presence of cardiotoxicity after the treatment of Hodgkin's disease with the standard ABVD or BEACOPP protocol. "
3.	Osteonecrosis (Kienbock's Disease) 05/01/2017 - "• Osteonecrosis is related to the corticosteroids included within the BEACOPP protocol. "

Related Drugs and Biologics

1.	Etoposide (VP 16)
2.	Cyclophosphamide (Cytoxan)
3.	Adrenal Cortex Hormones (Corticosteroids)